A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults

NCT05995249 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: TAK-279
DRUG: Erythromycin
DRUG: Phenytoin
DRUG: Efavirenz

Sponsor

Takeda